Literature DB >> 6896521

Plasma levels of glucagon-like polypeptides in patients with esophagoplasty.

G Tamburrano, A Lala, M Mauceri, F Tonelli, F Leonetti, D Andreani.   

Abstract

Seven patients with interposition of a jejunal tract between the esophagus and stomach or duodenum (EP group) and ten healthy normal volunteers have been submitted to an oral glucose load (OGTT) to clarify the significance of glucagon-like polypeptides (GLI) induced by glucose in carbohydrate metabolism. Blood glucose (BG) and GLI plasma levels were significantly higher in the EP group than in the normal one (p less than 0.01), respectively 30, 60, 90 min for BG and during all the test for GLI. The fasting immunoreactive glucagon (IRG) plasma levels were significantly lower in patients than in normals (p less than 0.05) whereas a marked and significant increase was observed in the EP group (p less than 0.01) from 90 to 240 min. The precocious stimulation of jejunal mucosa and the rapid intestinal transit which occur in these patients may explain the elevated GLI (probably glicentin) plasma levels. The rise in IRG plasma levels might be due to the enzymatic transformation of glicentin. The role of these types of glucagon on carbohydrate metabolism is still to be fully clarified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896521     DOI: 10.1007/BF03350500

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study.

Authors:  L I Larsson; J Holst; R Håkanson; F Sundler
Journal:  Histochemistry       Date:  1975-09-29

Review 2.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Glicentin: a precursor of glucagon?

Authors:  M Ravazzola; A Siperstein; A J Moody; F Sundby; H Jacobsen; L Orci
Journal:  Life Sci       Date:  1979-07-16       Impact factor: 5.037

4.  Glicentin immunoreactive cells: their relationship to glucagon-producing cells.

Authors:  M Ravazzola; A Siperstein; A J Moody; F Sundby; H Jacobsen; L Orci
Journal:  Endocrinology       Date:  1979-08       Impact factor: 4.736

5.  Enteroglucagon release in the dumping syndrome.

Authors:  S R Bloom; C M Royston; J P Thomson
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

6.  Gastric inhibitory polypeptide. Response to oral glucose after vagotomy and pyloroplasty.

Authors:  N R Thomford; K R Sirinek; S E Crockett; E L Mazzaferri; S Cataland
Journal:  Arch Surg       Date:  1974-08

7.  Effect of food ingestion on intestinal glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects.

Authors:  J Marco; J A Hedo; M L Villanueva; C Calle; A Corujedo; J M Segovia
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

8.  Transformation of glicentin-containing L-cells into glucagon-containing cells by enzymatic digestion.

Authors:  M Ravazzola; L Orci
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

9.  Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa.

Authors:  J M Polak; I Coulling; S Bloom; A G Pearse
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

10.  Plasma enteroglucagon and plasma volume change after gastric surgery.

Authors:  J P Thomson; S R Bloom
Journal:  Clin Sci Mol Med       Date:  1976-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.